Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

AvevoRx ANNOUNCES ENTRY INTO ALPHA-1 PROTEINAISE INHIBITOR MARKET, INCREASING THERAPEUTIC ACCESS FOR PATIENTS WITH RARE FORM OF CONGENITAL EMPHYSEMA


“AvevoRx brings the knowledge and infrastructure to provide services and programs typically expected of much bigger pharmacies while leveraging our adaptability and commitment to delivering an extraordinarily customized, personal patient experience.”

AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced it will provide Alpha-1 proteinase inhibitor drugs to patients with Alpha-1 antitrypsin deficiency as part of a nationwide clinical offering. This marks AvevoRx’s official entry into the Alpha-1 market, which is limited to a very small panel of specialized, home infusion pharmacy providers. Alpha-1 is the latest specialized infusion therapy offered by AvevoRx, whose primary specialties include immune globulin (IG) and monoclonal antibody treatments and acute infusion therapies such as IV antibiotics and total parenteral nutrition.

“We are delighted to join the Alpha1 community,” said Ric Logsdon, AvevoRx program manager for Alpha-1. “The company’s unique and robust management experience – over 150 years combined in Alpha-1 – positions us well to compete for the privilege of caring for this patient community.”

“We have an amazingly strong bench of Alpha-1 experience at every level of the organization, including pharmacy, nursing, customer service, consumer advocacy, billing, and finance,” commented Justin Dent, PharmD and AvevoRx’s national director of pharmacy operations. “AvevoRx brings the knowledge and infrastructure to provide services and programs typically expected of much bigger pharmacies while leveraging our adaptability and commitment to delivering an extraordinarily customized, personal patient experience.”

This class of drugs is intravenous biologicals derived from human plasma called Alpha-1 proteinase inhibitors. Each is used to treat a rare form of congenital emphysema, often caused by a patient’s Alpha-1 antitrypsin deficiency. The drugs are administered intravenously as often as every week, typically in the patient’s home or AvevoRx’s ambulatory infusion suites. Of the four drugs in this class currently approved for use in the U.S., AvevoRx will be dispensing and administering three of them.

Alpha-1 antitrypsin deficiency is a genetic disorder that could cause lung and liver disease in affected patients. The age at which the first signs and symptoms of the deficiency appear often varies, though resulting lung disease frequently develops between ages 25 and 50. Those affected often develop emphysema, a lung disease caused by damage to the air sacs in the lungs (alveoli). Roughly 10 percent of infants with an Alpha-1 antitrypsin deficiency will develop liver disease resulting in yellowing of the skin and eyes (jaundice); Approximately 15 percent of adults with the deficiency will develop liver damage (cirrhosis) due to the formation of scar tissue in the liver.

Testing for Alpha-1 antitrypsin deficiency is encouraged for those at high risk of inheriting this disorder, according to the Alpha-1 Foundation. Testing is available through a physician or can be conducted anonymously (Alpha-1 Foundation, 2022). For more information, visit http://www.alpha1.org.

About AvevoRx

AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients facing various complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies for patients with short-term therapeutic needs on a regional basis. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit http://www.AvevoRx.com or follow us on Instagram or LinkedIn.

Share article on social media or email:



A Natural Non-invasive Neuro-technology Improves Sleep and Wellbeing in Randomized, Controlled Clinical Trial


male client listening to their own brainwaves while relaxing in a zero gravity chair

A natural and non-invasive way for clients to help reset their own brain regulation by passive listening to their own brain waves which are translated to tones by the Cereset computer technology.

Sleep is foundational for optimal health, healing and well-being!

Cereset® (Ce – Cerebrum (brain) and Reset) is being used across the USA and in other countries as well as a means to provide clients a means to help reset their own brain regulation by passive listening to their own brain waves, which are translated to tones by the Cereset computer technology.

“Sleep is foundational for optimal health, healing and well-being,” said principal investigator Charles H. Tegeler, M.D., chair of neurology at Atrium Health Wake Forest Baptist, who led the team to investigate Cereset Research in a randomized controlled clinical trial. The effort compared patients with mild to moderate insomnia who listened to their own brain waves for 10 sessions of approximately an hour to those patients who were provided an active intervention using randomized tones for the same time.

The study concluded that there was a clinically significant insomnia improvement demonstrated over time by the Cereset Research group. The improvements in autonomic cardiovascular regulation were also significant for the Cereset Research group. Sleep quality, anxiety, and depression also improved. No adverse events were reported. The full study can be found in the SAGE Journal – Global Advances in Integrative Medicine and Health – see: https://doi.org/10.1177/27536130221147475.

“This study is a demonstration of our intent to help people help themselves and achieve a natural means to health and wellbeing,” said Lee Gerdes, Founder/CEO of Cereset. “Though we have 50 Cereset offices now in the USA, we hope to have double and triple that number in the near future to serve the many people we know have health and wellbeing compromises which we can assist them to rectify.”

To learn more about Cereset see: https://cereset.com, or to find a Cereset Client Center nearest you, see https://cereset.com/centers. To follow Cereset see: https://linkedin.com/company/cereset; https://facebook.com/wearecereset; https://instagram.com/wearecereset; or https://twitter.com/wearecereset

Financial support for this clinical trial was supported by a research grant from The Susanne Marcus Collins Foundation, Inc. Sean L. Simpson was supported by NIBIB R01EB024559 and Wake Forest Clinical and Translational Science Institute (WF CTSI) NCATS UL1TR001420. REDCap infrastructure for data collection and management was supported by UL1TR001420.

Share article on social media or email:



Brain Power Wellness Reviews Staff Retreat in Nicaragua


Participants of the Brain Power Wellness retreat in Nicaragua.

As Brain Power Wellness reviews the passing of another successful year, the holistic wellness organization highlights how it ended 2022 by hosting a staff retreat in Nicaragua. This retreat was a positive milestone for Brain Power Wellness as it was the company’s first time leading a staff retreat with an international group of corporate managers.

Brain Power Wellness leader Rebecca Wheaton has been connected with Nicaragua since she was thirteen years of age. Since her training to become a leader, Wheaton has taught professionally and voluntarily to local schools and non-profit organizations in Managua. Her relationship with Nicaragua has opened the doors for Brain Power Wellness to further look into avenues to bring the tools and wisdom Brain Power Wellness shares with schools a step further to the corporate world. The wellness company has continued conversations with Grupo Invercasa’s CO-CEO, Raul Amador, on this specific immersion goal.

INVERCASA, otherwise known as Grupo Invercasa, is authorized by the Superintendency of Banks and the Nicaraguan Stock Exchange as a Stock Exchange. With a team of highly qualified professionals ready for action, INVERCASA strives to offer clients personalized financial advice and trust and complete discretion for security purposes.

Twenty of INVERCASA’s general managers gathered in Nicaragua this past December 19th to participate in a Brain Power Wellness retreat for staff, guided by Brain Power Wellness leader Wheaton and her colleague Elizabeth Chavez.

“As BPW staff, we were graced with lively participation and positive engagement with this group of financial professionals. Despite having no prior knowledge of what to expect, the group took a deep dive into their own health and well-being and naturally made the important connection about how their inner work contributes to their stamina, focus, and joy in both their professional and personal life. It was a great joy to work with them,” said Wheaton.

During the retreat, staff members of Grupo Invercasa engaged in various activities that fueled understanding around self-care, team-building, the importance of family, and developing professional and personal goals. All activities were in sync with the three Brain Power Wellness steps that structured the retreat: Step #1: Connect with Self, Step #2: Professional Team Connection, and Step #3: Family Connection.

To kick off the start of the retreat, INVERCASA team members shared their personal and professional goals. Brain Power Wellness leaders then introduced self-care techniques, showing how to use breathing, stretching, holding postures, and dancing to open up physical blockages and become aware of where the body is holding tension. Diverse team games followed, along with a discussion about parenting tips, and the retreat ended with practicing a variety of Brain Breaks.

Brain Power Wellness experienced such tremendous success with the retreat, along with overwhelmingly positive feedback, that the wellness organization plans to return to Nicaragua in the soon future to pursue more chances to continue to connect meaningfully with corporate staff.

About Brain Power Wellness

Brain Power Wellness is a school-based wellness company that supports healthier school environments. Transforming partner schools through self-development, mindfulness, community building, retreats, SEL, holistic wellness, and brain training, Brain Power Wellness helps teachers, students, parents, and administrators. Since 2007, it has impacted more than 25,000 teachers and half a million students in 500 schools worldwide.

Share article on social media or email:

IO360º Summit Honors Women Leaders in Immuno-Oncology R&D


“We are so pleased to introduce the Women Leaders in IO luncheon to this year’s program, as a space for women to come together, share key learnings and discuss how to navigate the workforce.” – Kate Woda, Senior Director, IO360°

The Conference Forum announced two initiatives to honor women leaders in immuno-oncology including the publishing of the 4th annual “Women Leadership in Immuno-Oncology” and presenting the first-ever Women Leaders in IO Luncheon at the 2023 IO360º meeting on February 8th at the New York Marriott at the Brooklyn Bridge, in Brooklyn, NY.

“We are living in an exciting time as the field of immuno-oncology advances. More women than ever are working in the space and leading a wide range of scientific programs and initiatives,” said Valerie Bowling, Executive Director, The Conference Forum. “The Women Leadership in Immuno-Oncology series is a sampling of the many incredible women who are working to advance the field of immuno-oncology.”

This issue highlights 17 women who are working to advance IO efforts, and profiles their work at their organizations, their career paths and their advice to other women in science careers.

  • Stacey Adam, PhD, AVP, Research Partnerships, Foundation for the National Institutes of Health (FNIH)
  • Kelly Clark, Head of US Partnerships and Global Site Development, Merck
  • Teresa (Teri) Foy, PhD, SVP, Immuno-Oncology and Cell Therapy, BMS
  • Laurie Halloran, CEO, Halloran Consulting Group
  • Laura Johnson, PhD, Chief Scientific Officer, Head of R&D, Verismo Therapeutics
  • Shana Kelley, PhD, President, CTO & Co-founder, CTRL Therapeutics
  • Barbara Lavery, Chief Program Officer, Alliance for Cancer Gene Therapy
  • Wei Li, PhD, Chief Scientific Officer, Cytovia Therapeutics
  • Elaine Long, PhD, Scientific Leader, Immuno-Oncology, GE Healthcare Pharmaceutical Diagnostics
  • Marcela V Maus, MD, PhD, Director of Cellular Immunotherapy, MGH Cancer Center and Associate Professor, Harvard Medical School
  • Leanne Peiser, PhD, Executive Director, Translational Research, BMS
  • Kanya Rajangam, MD, PhD, Chief Medical and Development Officer, Senti
  • Isabelle Rivière, PhD, Director, Cell Therapy and Cell Engineering Laboratory, Memorial Sloan Kettering Cancer Center
  • Ana Rosa Sáez Ibáñez, PhD, Research Analyst, Clinical Accelerator and Venture Fund, Cancer Research Institute
  • Barbra Sasu, PhD, Chief Scientific Officer, Allogene Therapeutics
  • Leah Sibener, PhD, Co-founder, VP, Head of Therapeutic Discovery, 3T Biosciences
  • Shivani Srivastava, MD, VP, Development Program Lead, Cell Therapy Development, BMS

The entire profile series can be accessed by clicking here.

The Women Leaders in IO luncheon, February 8, 2023 will include a panel that addresses both the challenges and opportunities for women working in immuno-oncology, such as unconscious bias, negotiation skills and career advice.

“We are so pleased to introduce the Women Leaders in IO luncheon to this year’s program,” said Kate Woda, Senior Director, IO360º, “as a space for women to come together, share key learnings and discuss how to navigate the workforce.”

The discussion will be moderated by:

  • Katie McCarthy, Chief Innovation Officer, Halloran Consulting Group
  • Jill O’Donnell-Tormey, PhD, CEO & Director, Scientific Affairs, Cancer Research Institute (CRI)

The panelists are:

  • Lisa Butterfield, PhD, Adjunct Professor of Microbiology and Immunology, University of California San Francisco (UCSF)
  • Priti Hegde, PhD, CSO, Foundation Medicine
  • Rosanna Ricafort, MD, VP and Head, Cellular Therapy Clinical Development, BMS
  • Raluca Verona, PhD, Head, Heme Malignancies, Translational Research, Janssen R&D

To learn more about the event, visit io360summit.com

About Immuno-Oncology 360º:

IO360˚ is an annual conference in NYC that convenes key stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

About the Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. The company also publishes six newsletters and produces PharmaTalkRadio and virtual events.

Share article on social media or email:

Prominent Aging in Place Executive Dr. Amy Schiffman Joins Sympathy Brands


I am excited to be a part of Sympathy Brands and to bring new and innovative resources to educate on aging. It is exciting that Sympathy Brands is furthering the connection between families and the deathcare industry with this new curriculum, said Dr. Schiffman.

The Sympathy Brands Family of Brands, including shiva.com, eCondolence.com, Cemetery.com, Jewish Funeral Group, and others, is excited to announce Dr. Amy Schiffman, a nationally recognized expert in aging in place has joined the company.

Dr. Schiffman will work closely with the team to broaden Sympathy Brands’ educational support, seminars, training, and resources for families and the deathcare industry.

Dr. Schiffman brings extensive experience and knowledge to the company as she leads the curriculum development surrounding aging in place and provides guidance on supporting resources. She is currently the Chief Medical Officer at a Jewish Human Services Agency where she manages all aging in place services including hospice, private duty / homecare, care coordination, and the Holocaust Survivor Program. Prior to her most recent role, Dr. Schiffman served as an Emergency Physician, started a Medicare home-based primary care practice, and served as a medical director at two hospices. She is both a board-certified Emergency Medicine physician with a medical degree from George Washington University School of Medicine and a certified Hospice Medical Director as well as having a graduate degree in public health from the Bloomberg Johns Hopkins School of Public Health, along with an undergraduate degree from University of Pennsylvania.

“We are thrilled and honored to have Amy leading such an important area of the company. Her expertise and experience will be invaluable as we continue to expand our offerings and support for both families and the deathcare industry,” said Michael Schimmel, CEO of Sympathy Brands.

Dr. Schiffman will guide the team on the development and implementation of programs and initiatives. The primary areas of focus include adding educational seminars focused on aging in place, Medicare, and aging Jewishly, creating a library for end-of-life planning resources, including training materials and support for the deathcare industry, along with family-focused tools such as guides, checklists, and other resources. Through shiva.com, eCondolence.com, and Sympathy Brands, Dr. Schiffman will be sharing and helping implement best practice guidance for families and professionals.

“I am excited to be a part of Sympathy Brands and to bring new and innovative resources to educate on aging,” said Dr. Schiffman. “Aging in place is a confusing and challenging topic, and it is exciting that Sympathy Brands is furthering the connection between families and the deathcare industry with this new curriculum.”

About Sympathy Brands Company

Sympathy Brands is the parent company for shiva.com, JewishFuneralGroup.com, eCondolence.com, SympathyBrands.com, Cemetery.com and others. The company mission is to support families and industry experts through all stages of end-of-life matters™ with its trusted marketplace, leading technology and highly curated network of strategic partners. To learn more, please visit SympathyBrands.com.

Share article on social media or email:

Dental Care Alliance Welcomes Racine Dental Group of Wisconsin


“With a 50-year legacy of partnership, servant leadership, and dedication to the communities they serve, it was very clear that Racine Dental Group would be an outstanding addition to the Alliance,” shared Ryan Zeman, DCA Vice President Business Development

Dental Care Alliance (DCA) is proud to welcome Racine Dental Group of Racine, Wisconsin to its growing portfolio of world-class practices. Located in the growing lakefront community of Racine, Racine Dental Group is an 85-operatory and 65,000 square foot facility with a satellite pediatric dental location in Lake Geneva.

Racine Dental Group provides high-quality dental care to people of all ages living in and around Racine, Wisconsin. Patients enjoy the convenience of having a full range of services under one roof, including General Dentistry, Pediatric Dentistry, Dental Implants, Cosmetic Dentistry, Endodontics, Oral Surgery, Orthodontics/Invisalign, Periodontics, Treatments for Sleep Apnea and TMJ Disorder.

Racine Dental Group began as the fulfillment of a dream five dentists shared in the early 1960’s. These dentists wanted to offer Racine, WI the first dental group experience. They believed that if they combined resources, they could offer patients the best dental technology available. Today, the practice has grown to include 13 general dentists, three pediatric dentists, one oral surgeon, two endodontists and one periodontist, but everyone continues to share the same goal the practice was found on – to provide professional, courteous, and technically innovative dental care to people in the Racine and surrounding communities.

The practice is built on a foundation of communication and patient education. Racine Dental dentists and staff treat patients like family. They care for them as they do their own loved ones, and aim to make every visit as gentle, pain free and pleasant as possible. The practice has earned the honor of being accredited by the AAAHC, or the Accreditation Association for Ambulatory Health Care.

The practice also takes pride in giving back to the community that they have called home for almost 45 years. Racine Dental Group employees volunteer in schools and with local non-profits, contributing efforts to organizations including the American Cancer Society, the American Lung Association, and local sports teams.

This affiliation continues the rapid growth and momentum for the organization and brings DCA’s footprint in Wisconsin to 15 allied practices, and DCA’s total footprint to over 390 allied practices across the US.

“With a 50-year legacy of partnership, servant leadership, and dedication to the communities they serve, it was very clear that Racine Dental Group would be an outstanding addition to the Alliance,” shared Ryan Zeman, Vice President Business Development. “Along with Modern Dental Care’s exceptional partners, team, and leadership, we are so proud of who will be representing DCA’s mission, vision, and values while also providing an unrivaled ability to positively impact the lives of so many families throughout Wisconsin.”

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 390 allied practices and supports over 900 dentists across 22 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names.

Share article on social media or email:

Chacruna’s Diversity, Culture and Social Justice in Psychedelics Course


“The level of expertise was exceptional, along with how kind, supportive, and approachable it was to interact with them personally and with their content.” – Tahlia Harrison, MA, MFTA, LMT, Therapist, Doctoral Student, and graduate of our last Diversity course.

The first of its kind in the psychedelic field, the course is interdisciplinary, experiential, personal and intellectual. Classes will introduce students to critical topics in cultural, historical, scientific and socioeconomic contexts that have shaped – and continue to influence – the psychedelic renaissance. The course will have a special focus on providing foundational knowledge in psychedelics and justice, diversity, equity and inclusion (JEDI). Students will explore implicit bias, queer aspects, intersectionality, cultural humility, social identity, healing the racial divide, uses of Indigenous plant medicines and challenges around the mainstreaming and globalization of psychedelics.

Each class is taught by international experts in the field, whose perspectives shed light on how psychedelics influence and are influenced by social justice, privilege, and diversity. Faculty include Dr. Bia Labate, Dr. Monnica Williams, Dr. Sonya Faber, Dr. Joseph McCowen, Dr. Clancy Cavnar, Dr. Alex Belser, Dr. Darron Smith and Lígia Platero.

According to Chacruna’s Executive Director, Bia Labate, PhD, the program presents a unique opportunity for students of psychedelic science and culture to gain a deep understanding of historical context, contemporary topics, and future opportunities within the psychedelic world. “Many people are not aware of both the potential pitfalls of psychedelics, and the fact that this movement did not start in the counterculture or in the labs of white male scientists,” she shares. “It’s important to have an understanding of the field to move forward in mindful ways.”

These classes are “essential as we move into the new psychedelic renaissance,” says Dr. NiCole Buchanan, Ph.D., who is part of Chacruna’s Board of Directors: “This course will help all of us improve our competence working with diverse communities, and will expand knowledge of the challenges that might arise when working with those from different backgrounds,” she adds.

Dr. Clancy Cavnar will dive into the diverse history of the field in her class, ”Queer Aspects of Psychedelic Experience.” “The study of queer people’s past histories with psychedelics will help inform clinicians of the sensitivity of the subject for this population, especially in regard to ‘conversion therapy,’” she says.

“The joy of the exploration of alternate states of reality has long been a secret of outsiders in our culture, queer people being among the most creative and prolific users of these substances,” she continues. “The culture that arose around this and its influence on popular culture is fascinating.”

Courses are open to students from all professional backgrounds, including those who want to pursue deeper knowledge of psychedelic culture and science. Since its inception, Chacruna Institute has been an inspiration and reference for the many institutions that have begun offering psychedelic trainings and studies, including Stanford University, Naropa University, CIIS, Vital, Psychiatry Institute, Psychedelic Support, Synthesis Institute, UC Berkeley, InnerTreck, Synaptic Institute, University of Ottawa, and many others. Chacruna students and team members have worked as professors, advisors and consultants in these and other organizations across the world. Through this course, Chacruna will “continue to promote and nourish the creation of a new generation of psychedelic therapists and practitioners, who are more needed than ever as we move forward with this psychedelic renaissance,” says Labate.

Get more information and register here. CE credits are available, and students have an option to receive a Certificate of Completion from Chacruna. Classes start February 6.

Share article on social media or email:

Saul Behar to Chair Reinvestment Fund’s Board of Directors


Reinvestment Fund has elected Saul A. Behar as the new Chair of its Board of Directors. In this role, he will champion the efforts of the Board, ensuring that the organization remains accountable in its mission to build strong, healthy, and more equitable communities.

“I am honored to help lead and shape Reinvestment Fund’s work by contributing my expertise in this new role,” said Mr. Behar. “I am grateful to outgoing chair Mark Zandi for his outstanding leadership and service. I look forward to continuing to work with the Board and Reinvestment Fund’s highly skilled professional staff.”

Mr. Behar has served on Reinvestment Fund’s Board of Directors since 2016. In this capacity, he has been a valuable advisor as Reinvestment Fund remained focused on delivering their mission in the face of a pandemic, racial reckoning, and divisive politics. Prior to his appointment as Chair, he served on the Loan Committee, chaired the Audit Committee, and most recently served as Vice Chair of the Board.

“We are pleased to have Saul serve in this leadership role on our Board,” said Don Hinkle-Brown, President and CEO of Reinvestment Fund. “He brings extensive knowledge of business operations at all stages. We are particularly excited about his commitment to inclusive economic growth and to supporting entrepreneurs as they scale their businesses, create jobs, and improve lives.”

Mr. Behar serves as Senior Vice President of Strategic Initiatives and General Counsel at the University City Science Center in Philadelphia, which advances healthcare innovation from idea to the marketplace through startup support services and building inclusive STEM pathways for local youth and adults. He is a graduate of Cornell University and The University of Chicago Law School.

In addition to Mr. Behar’s appointment, the Reinvestment Fund’s Board welcomes three additional board members: Cynthia F. Figueroa, Wendell Pritchett, and Melissa Weiler Gerber. Ms. Figueroa is the President and CEO of JEVS Human Services, a not-for-profit, nonsectarian social service agency based in Philadelphia. Dr. Pritchett is the James S. Riepe Presidential Professor of Law and Education at the University of Pennsylvania. Ms. Weiler Gerber serves as the President & CEO of AccessMatters, a nonprofit, public health organization located in Center City Philadelphia.

“Our candidate search was focused on boosting our local Philadelphia regional representation,” said Mr. Hinkle-Brown. “Cynthia, Wendell, and Melissa bring diverse expertise that can help to expand our areas of strength. We are pleased to have the wisdom from their backgrounds and varied experiences to help shape our work in the coming years.”

# # #

About Reinvestment Fund

Reinvestment Fund is a mission-driven financial institution committed to making communities work for all people. We bring financial and analytical tools to partnerships that work to ensure that people in communities across the country have the opportunities they strive for: affordable places to live, access to nutritious food and health care, schools where their children can flourish, and strong, local businesses that support jobs. We use data to understand markets and how transactions can have the most powerful impact, which has consistently earned us the top Aeris rating of AAA for financial strength and four stars for impact management. Our asset and risk management systems have also earned us an A+ rating from S&P. Since our inception in 1985, Reinvestment Fund has provided over $2.4 billion in financing to strengthen neighborhoods, scale social enterprises, and build resilient communities. Learn more at reinvestment.com.

Share article on social media or email:

Expanded Offerings to Support Certified Emergency, Transport and Trauma RNs Featured in BCEN 2022 Annual Report


News Image

“In 2022, we debuted BCEN Learn Live, our first self-hosted conference, and the offerings on our award-winning BCEN Learn professional development platform grew markedly,” said BCEN CEO Janie Schumaker.

Expanded offerings to help board certified emergency, transport and trauma RNs earn and maintain their specialty credentials are featured in the 2022 annual report released today by the Board of Certification for Emergency Nursing (BCEN).

“In 2022, BCEN continued to offer support to nurses based on direct feedback from our certification holders,” said BCEN CEO Janie Schumaker, MBA, BSN, RN, CEN, CENP, CPHQ, FABC. “We debuted BCEN Learn Live, our first self-hosted conference, and the offerings on our award-winning BCEN Learn professional development platform grew markedly, providing anywhere, anytime advanced education that can be used immediately in clinical practice, leadership and teamwork.”

More specifically, the BCEN Learn platform, which launched in fall 2020, now offers more than 85 highly interactive, state-of-the-art continuing education (CE) courses designed specifically for RNs working across the emergency spectrum, as well as two dozen free CE webinars, 52 podcast episodes, a new unlimited player game for pediatric emergency nurses, and full length practice exams.

The first BCEN Learn Live Conferences—featuring live TED-style CE sessions designed specifically for board certified nurses—were held in coastal Alabama and Las Vegas, with 2023 conferences scheduled for Dallas (May) and Charlotte (November).

Highlights of 2022 include:

  • Nearly 50,000 RNs across 26 countries hold one or more BCEN credential
  • The number of Trauma Certified Registered Nurses (TCRNs) tops 7,000 for the first time
  • 24% increase in RNs holding the CTRN critical care ground transport credential (for a third straight year of record growth, following 19% and 29% increases in 2020 and 2021, respectively)
  • Development of the world’s first burn nursing credential, the Certified Burn Registered Nurse (CBRN), proceeds on schedule
  • BCEN debuts its first self-hosted conference, BCEN Learn Live
  • New BCEN Learn “Build Your Own Bundle” allows RNs to create custom CE course bundles and save
  • $155,000 in BCEN scholarships is awarded to 47 RNs, nursing students, and paramedics becoming RNs
  • 16% increase in healthcare facilities using the BCEN Voucher Program, with over 5,000 RNs getting certified or recertified via voucher since vouchers were introduced in 2016

View BCEN’s 2022 Annual Report infographic here:

https://bcen.org/wp-content/uploads/2023/01/2022-BCEN-Year-in-Review.pdf

About BCEN

Founded in 1980, the independent, not-for-profit Board of Certification for Emergency Nursing (BCEN®) offers robust certification programs fostering empowered nurses across the emergency spectrum who contribute noticeably to patient care, safety and outcomes. Nearly 59,000 BCEN board certifications are held by registered nurses (RNs) who specialize in emergency, flight, critical care ground transport, pediatric emergency and trauma nursing. BCEN offers the Certified Emergency Nurse (CEN®), Certified Flight Registered Nurse (CFRN®), Certified Pediatric Emergency Nurse (CPEN®), Certified Transport Registered Nurse (CTRN®) and Trauma Certified Registered Nurse (TCRN®) certifications. Through the award-winning BCEN Learn continuing education platform and the BCEN Learn Live conferences, BCEN supports advanced emergency nursing lifelong learning. Learn more at bcen.org. Follow BCEN on Facebook, LinkedIn and Instagram.

# # #

Share article on social media or email:

Traliant Announces New Health & Wellness Suite of Online Training Courses


News Image

“Our new health and wellness suite provides a positive way for organizations to support mental and physical well-being and encourage trust and psychological safety — key factors in creating a work culture where employees can thrive.”John Arendes, Traliant CEO

Traliant, an innovator in online compliance training, today announced a new suite of interactive courses focused on helping organizations support employee mental health and wellness and build a psychologically safe work culture. Traliant’s Making a Commitment to Health and Wellness suite provides insights and practical actions that foster a workplace that promotes and encourages mental and physical well-being.

Making a Commitment to Health and Wellness comprises eight brief, targeted courses, each exploring a different dimension: emotional, environmental, financial, intellectual, occupational, physical, social and spiritual wellness. Employees gain greater awareness and understanding of how the dimensions interconnect, how to reduce stress and burnout and be more engaged and productive.

For more information, please visit: Making a Commitment to Health and Wellness

A key part of building a culture that supports employee well-being is recognizing the importance of balancing work and personal life. Traliant’s recent survey of 2,000 full-time US employees uncovered that 47.1% of respondents are prioritizing their mental health more, with 48.9% prioritizing family and personal life more.

“The evolving workplace and the need for greater work-life balance is making health and wellness a priority for organizations and their employees,” said John Arendes, Traliant CEO. “Our new health and wellness suite provides a positive way to support mental and physical well-being and encourage trust and psychological safety — key factors in creating a work culture where employees can thrive.”

As leaders look to attract and retain talent, data shows that health and wellness will remain center stage for potential and existing employees.

“With burnout, stress and worries about the future increasing, employees are focusing on their mental health and well-being as never before,” said Maggie Smith, Traliant Senior Vice President of Human Resources. “By providing training and other resources, organizations can demonstrate their commitment to addressing employees’ personal needs and meeting recruiting and retention challenges, now and in the future.”

Traliant’s Making a Commitment to Health and Wellness suite addresses the eight dimensions of well-being, exploring how each is essential in building a healthy, productive workforce and culture. Each 10-minute course focuses on one aspect of health and wellness. Interactive challenges, viewer emails and tweets address common questions and prompt learners to think about how they can positively impact each dimension.

Traliant’s training courses can be translated into 100+ languages and be easily customized to reflect an organization’s workplace and workforce.

About Traliant  

Traliant’s mission is to transform online compliance training from boring to brilliant. We are helping thousands of organizations foster safe, ethical cultures of respect and inclusion with behavior-based solutions that can be easily customized to their industry, culture, and branding. Backed by PSG, a leading growth equity firm, Traliant is ranked on Inc.’s 2021 and 2022 list of the 5000 fastest-growing private companies in America. For more information, visit http://www.traliant.com and follow us on LinkedIn.

Share article on social media or email: